image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates and Ideas

Cambridge Cognition - Quality of earnings improves

May 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • COG
  • Price:
  • 114.5p
At the heart of Cambridge Cognition’s (COG; 114.5p) operation are tests that were developed at Cambridge University over a period of 30 years to test cognitive function (such as thinking, reasoning and remembering) in order to test for Alzheimer’s disease and dementia. As we all know, Alzheimer’s is an incurable disease that slowly impairs your memory and thinking skills and, eventually, the ability to care for yourself. Considerable research is being carried out in the area.During the month I met with CEO Dr Steven Powell and was shown a couple of examples of the company’s tests to try. In the old days such tests were paper based but COG has launched versions for PCs and Ipads. The tests I saw were in the f ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW